Moderna, Inc. — Director's Dealing 2022

Jun 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2022-06-08

Reporting Person: Andres Juan (See remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-08	Common Stock	M	1371	$20.93	Acquired	11738	Direct
2022-06-08	Common Stock	M	2000	$20.93	Acquired	13738	Direct
2022-06-08	Common Stock	M	2000	$20.93	Acquired	15738	Direct
2022-06-08	Common Stock	M	2000	$20.93	Acquired	17738	Direct
2022-06-08	Common Stock	M	2000	$20.93	Acquired	19738	Direct
2022-06-08	Common Stock	M	629	$14.22	Acquired	20367	Direct
2022-06-08	Common Stock	S	10000	$150.00	Disposed	10367	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-08	Stock Option (Right to Buy)	$20.93	M	1371	Disposed	2029-03-08	Common Stock (1371)	Direct
2022-06-08	Stock Option (Right to Buy)	$20.93	M	2000	Disposed	2029-03-08	Common Stock (2000)	Direct
2022-06-08	Stock Option (Right to Buy)	$20.93	M	2000	Disposed	2029-03-08	Common Stock (2000)	Direct
2022-06-08	Stock Option (Right to Buy)	$20.93	M	2000	Disposed	2029-03-08	Common Stock (2000)	Direct
2022-06-08	Stock Option (Right to Buy)	$20.93	M	2000	Disposed	2029-03-08	Common Stock (2000)	Direct
2022-06-08	Stock Option (Right to Buy)	$14.22	M	629	Disposed	2028-02-28	Common Stock (629)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021.

F2: 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

F3: This option is fully vested and exercisable.